Explore more publications!
Mauritius Healthcare Daily
Got News to Share?

Mauritius Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mauritius Healthcare Daily.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 23, 2026

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
Apr. 23, 2026

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
Apr. 23, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation

Indeterminate GlobeNewswire
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026
Apr. 23, 2026

Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026

Indeterminate GlobeNewswire
Noom Health’s SmartRx Program on Track to Cut Employer’s GLP-1 Spend by Nearly 80%
Apr. 23, 2026

Noom Health’s SmartRx Program on Track to Cut Employer’s GLP-1 Spend by Nearly 80%

Indeterminate GlobeNewswire
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
Apr. 23, 2026

Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

Indeterminate GlobeNewswire
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
Apr. 23, 2026

Collegium to Report First Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
Apr. 23, 2026

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire
electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation
Apr. 23, 2026

electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

Indeterminate GlobeNewswire
MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio
Apr. 23, 2026

MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio

Indeterminate GlobeNewswire
Atsena Therapeutics Announces Upcoming Presentations at Scientific and Medical Meetings
Apr. 23, 2026

Atsena Therapeutics Announces Upcoming Presentations at Scientific and Medical Meetings

Indeterminate GlobeNewswire
Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States
Apr. 23, 2026

Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States

Indeterminate GlobeNewswire
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
Apr. 23, 2026

Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications

Indeterminate GlobeNewswire
Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform
Apr. 23, 2026

Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform

Indeterminate GlobeNewswire
Belite Bio to Participate in Four Upcoming Investor Conferences
Apr. 23, 2026

Belite Bio to Participate in Four Upcoming Investor Conferences

Indeterminate GlobeNewswire
CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
Apr. 23, 2026

CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)

Indeterminate GlobeNewswire
GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite
Apr. 23, 2026

GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite

Indeterminate GlobeNewswire
Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit
Apr. 23, 2026

Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit

Indeterminate GlobeNewswire
Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™
Apr. 23, 2026

Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

Indeterminate GlobeNewswire
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
Apr. 23, 2026

Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors

Indeterminate GlobeNewswire
Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
Apr. 23, 2026

Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions